Search Results for “diabetes” – Page 50 – media

Like a baby– The vicious cycle of childhood obesity and snoring

Poor nutrition and lack of exercise lead to the increasing prevalence of obesity which, in turn, is the major predictor of diabetes and future risk of cardiovascular disease in western societies. v
- Source: medicalxpress
- 541
- November 20, 2017
cardiovascular disease diabetes obesity obstructive sleep apnea
Gene prompts cells to store fat, fueling obesity

Obesity is often attributed to a simple equation: People are eating too much and exercising too little. But evidence is growing that at least some of the weight gain that plagues modern humans is predetermined.
- Source: sciencedaily
- 642
- November 14, 2017
ankyrin-B gene obesity Researches
Dynavax Announces FDA Approval of HEPLISAV-B™ for Prevention of Hepatitis B in Adults

Dynavax Technologies Corporation (NASDAQ: DVAX) announced that the U.S. Food and Drug Administration (FDA) has approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in the United States in more than 25 years and the only two-dose hepatitis B vaccine for adults.
- Source: investors.dynavax
- 566
- November 13, 2017
FDA hepatitis B Heplisav-B
Mobile Digital health has the potential to save $46 billion a year in health spending

Existing digital health products hold the potential to save the nation $46 billion in healthcare spending if they’re deployed comprehensively, according to a new report from IQVIA, which on Tuesday renamed itself from Quintiles/IMS Health.
- Source: healthcareitnews
- 591
- November 9, 2017
asthma cardiac diabetes healthcare Market Views
Increasing rates of chronic conditions putting more moms, babies at risk

Pregnant women today are more likely to have chronic conditions that could cause life-threatening complications than at any other time in the past decade - particularly poor women and those living in rural communities, a new Michigan Medicine study suggests.
- Source: Medicalxpress
- 390
- November 8, 2017
chronic conditions Researches
Merck subsidiary StayWell acquires app maker MedHelp for undisclosed sum

To expedite its push into mobile health, Yardley, Pennsylvania-based StayWell announced today that it has acquired the mobile health portion of Silicon Valley-based MedHelp, which includes several consumer-facing mobile health apps.
- Source: mobihealthnews
- 496
- November 6, 2017
Company Insight health apps MedHelp Merck
The fight against obesity–To tax or not to tax?

The debate explores whether food taxation is an indispensable strategy to correct obesity trends, or whether there should be other ways of approaching the problem.
- Source: Medicalxpress
- 500
- November 6, 2017
food taxation obesity
China’s Import and Export Report of Antineoplastic Drugs

Antineoplastic or anticancer drugs, affect the process of cell division i.e. are antiproliferative. They damage the DNA and initiate apoptosis, preventing the development and spread of neoplastic cells. Commonly used antineoplastic drugs can be divided into the following six categories: alkylating agents, anti-metabolites, anticancerous, antibiaties, aminoglutethimide and others. Today, Ddu, the leading global pharmaceutical & medical device B2B online platform, shares China’s Import and Export Report of Antineoplastic Drugs with you. General situation of global market of antineoplastic drugs According to the IMS’s latest report, “Global Oncology Trends 2017” showed that in 2016 the global market sales of antineoplastic drugs were 89.6 billion USD and 85 billion USD in 2015. Over the past five years, the global market of antineoplastic drugs has grown at a compound annual growth rate (CAGR) of 8.7% and is expected to exceed 147 billion USD by 2021. As indicated on the chart, the United States, the European Union and Japan are still the driving ...
- Source: Ddu
- 1,499
- November 3, 2017
anticancer Antineoplastic Market Reports neoplastic cells
Sanofi, Regeneron’s biologic shines again in asthma trial

Regeneron and Sanofi have unveiled positive new data from a late-stage trial investigating the biologic dupilumab in adults and adolescents 12 years of age and older with severe, steroid dependent asthma.
- Source: Pharmatimes
- 1,076
- November 3, 2017
asthma Clinical Trial dupilumab
Drug can dramatically reduce weight of people with obesity

A drug that targets the appetite control system in the brain could bring about significant weight loss in people with clinical obesity, according to new research.
- Source: Sciencedaily
- 658
- October 27, 2017
obesity semaglutide weight loss

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.